| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 230,360 | 218,971 | 189,843 | | Cost of Revenue | 116,556 | 102,291 | 90,129 | | | Gross Profit | 113,804 | 116,680 | 99,714 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 79,017 | 71,159 | 63,019 | | Non Recurring |
-
|
-
|
-
| | Others | 5,647 | 3,589 | 2,070 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 29,140 | 41,932 | 34,625 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,445 | 6,142 | 6,819 | | Earnings Before Interest And Taxes | 31,585 | 48,074 | 41,444 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 31,585 | 48,074 | 41,444 | | Income Tax Expense | 10,117 | 16,012 | 14,049 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,468 | 32,062 | 27,395 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 21,468 | 32,062 | 27,395 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,468 | $32,062 | $27,395 |
|
1.48% Nasdaq 
Income Statement
